FDA Inspection 1028357 — Yangzhou Liberty Pharmaceuticals Co. Ltd.
The FDA completed an inspection of Yangzhou Liberty Pharmaceuticals Co. Ltd. on September 15, 2017 in Yangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 15, 2017
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Yangzhou (China)